Eisai Introduced Malaysia’s First Disease-Modifying Treatment For Early Alzheimer’s Disease
KUALA LUMPUR, 13 JULY 2026 – Eisai Malaysia, the local affiliate of global research-based pharmaceutical company Eisai Co, Ltd., has introduced LEQEMBI (lecanemab), Malaysia’s first disease-modifying therapy (DMT) for Alzheimer’s…